Use of Glubran 2 ® in Axillary Lymphadenectomy Without Drain
Seroma Control in Axillary Lymphadenectomy With Glubran 2® Without Drain. Multicenter, Prospective, Randomized Clinical Trial. GALA-ND Study (Glu Axillary Lymphadenectomy Ambulatory- no Drain)
Omphis Foundation
134 participants
Apr 1, 2022
INTERVENTIONAL
Conditions
Summary
Axillary lymphadenectomy in breast cancer continues to be a common practice in certain patients. The use of sealants and drains continues to be a source of disagreement among the scientific community. That is why the study was designed to show whether the sealant reduces seroma after axillary lymphadenectomy without drainage.
Eligibility
Inclusion Criteria2
- Over 18 years old
- Conservative surgery for breast cancer with associated axillary lymphadenectomy
Exclusion Criteria5
- Mastectomy
- History of axillary surgery or ipsilateral axillary radiotherapy
- ASA 4 patients. (ASA 3 patients selected)
- Lack of adequate cognitive capacity and/or signed informed consent
- Pregnancy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Application of Glubran 2 sealant (liquid) in axillary hollow
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05280353